| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9000781 | Farmacia Hospitalaria | 2005 | 8 Pages |
Abstract
Therapies based on non-nucleoside reverse transcriptase inhibitors and protease inhibitors (PIs) have shown similar effectiveness to increase CD4+ cell counts. Regarding viral load decreases, protease inhibitors were most effective. Therapies using three nucleoside reverse transcriptase inhibitors resulted in peak survival.
Related Topics
Health Sciences
Pharmacology, Toxicology and Pharmaceutical Science
Pharmaceutical Science
Authors
U. Cilveti-Sánchez, M. Arenere Mendoza, H. Navarro Aznárez, M.J. Rabanaque Hernández, M.A. Allende-Bandrés, M. Mendaza Beltrán,